CD8A and neoplasm: TIGIT has been shown to be up-regulated on activated CD4 T cells, including Tregs, natural killer (NK) cells (1, 2), tumor antigen-specific CD8+ T cells and on NK cells where, when engaged, TIGIT directly inhibits cytotoxicity (3).